Leonteq Securities’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26K Hold
304
– – ﹤0.01% 890
2026
Q2
$35.6K Buy
+304
New +$30.5K ﹤0.01% 869
2024
Q4
– Sell
-5,000
Closed -$195K – 1305
2024
Q3
$195K Hold
5,000
– – 0.01% 494
2024
Q2
$171K Hold
5,000
– – 0.01% 516
2024
Q1
$126K Hold
5,000
– – 0.01% 599
2023
Q4
$148K Hold
5,000
– – 0.01% 562
2023
Q3
$158K Hold
5,000
– – 0.01% 573
2023
Q2
$129K Hold
5,000
– – 0.01% 622
2023
Q1
$120K Hold
5,000
– – 0.01% 622
2022
Q4
$97.5K Buy
+5,000
New +$98.8K ﹤0.01% 673

Other funds holding MIRM

Leonteq Securities's MIRM Position: Q3 2026 in Review

Leonteq Securities held its Mirum Pharmaceuticals (MIRM) position steady in Q3 2026 at 304 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

Leonteq Securities first reported a position in MIRM in Q4 2022 and has held it in 10 quarters since. The position peaked at $195K in Q3 2024. 236 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Leonteq Securities held 304 shares of Mirum Pharmaceuticals worth $26K as of Q3 2026.
  • Leonteq Securities left its Mirum Pharmaceuticals share count unchanged in Q3 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #890 holding.
  • Leonteq Securities first reported a position in Mirum Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
  • Leonteq Securities's Mirum Pharmaceuticals position peaked at $195K in Q3 2024.
  • 236 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.